LUMIRA Trademark

Trademark Overview


On Monday, July 29, 2024, a trademark application was filed for LUMIRA with the United States Patent and Trademark Office. The USPTO has given the LUMIRA trademark a serial number of 98671312. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, February 20, 2025. This trademark is owned by Roche Diagnostics GmbH. The LUMIRA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Chemical, biological and biochemical preparations for the analysis of biological samples for medical purposes; medical diagnostic assays and reagents for the analysis of biological samples for clinical or medical purposes; diagnostic reagents and preparations for medical purposes; in vitro diagnostic agents for the analysis of biological samples for medical purposes; all of the foregoing excluding active pharmaceutical ingredients, isotopes and radioisotopes

Analyzers for the analysis of biological samples for medical diagnostic purposes
lumira

General Information


Serial Number98671312
Word MarkLUMIRA
Filing DateMonday, July 29, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, February 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemical, biological and biochemical preparations for the analysis of biological samples for medical purposes; medical diagnostic assays and reagents for the analysis of biological samples for clinical or medical purposes; diagnostic reagents and preparations for medical purposes; in vitro diagnostic agents for the analysis of biological samples for medical purposes; all of the foregoing excluding active pharmaceutical ingredients, isotopes and radioisotopes
Goods and ServicesAnalyzers for the analysis of biological samples for medical diagnostic purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 29, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, July 29, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRoche Diagnostics GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMannheim 68305
DE

Trademark Events


Event DateEvent Description
Monday, July 29, 2024NEW APPLICATION ENTERED
Tuesday, September 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 10, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, September 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 21, 2025ASSIGNED TO EXAMINER
Thursday, January 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 24, 2025NON-FINAL ACTION E-MAILED
Friday, January 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 24, 2025NON-FINAL ACTION WRITTEN
Wednesday, February 19, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 19, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 20, 2025TEAS/EMAIL CORRESPONDENCE ENTERED